CU24319B1 - QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS - Google Patents

QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS

Info

Publication number
CU24319B1
CU24319B1 CUP2015000028A CU20150028A CU24319B1 CU 24319 B1 CU24319 B1 CU 24319B1 CU P2015000028 A CUP2015000028 A CU P2015000028A CU 20150028 A CU20150028 A CU 20150028A CU 24319 B1 CU24319 B1 CU 24319B1
Authority
CU
Cuba
Prior art keywords
derived
formula
amina
quinolin
quinoxaline
Prior art date
Application number
CUP2015000028A
Other languages
Spanish (es)
Other versions
CU20150028A7 (en
Inventor
Florence Mahuteau
Romain Najman
Jamal Tazi
Original Assignee
Abivax
Centre Nat Rech Scient
Inst Curie
Univ Montpellier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP20090305540 external-priority patent/EP2266972A1/en
Application filed by Abivax, Centre Nat Rech Scient, Inst Curie, Univ Montpellier filed Critical Abivax
Priority claimed from PCT/IB2010/052652 external-priority patent/WO2010143170A2/en
Publication of CU20150028A7 publication Critical patent/CU20150028A7/en
Publication of CU24319B1 publication Critical patent/CU24319B1/en

Links

Abstract

<p>Un compuesto de fórmula (I) o sales farmacéuticamente aceptables de los mismos, donde las sales farmacéuticamente aceptables son seleccionadas de hidrobromada, tartrato, citrato, trifluoroacetato, ascorbato, hidroclorido, tartrato, triflato, maleato, mesilato, formato, acetato y fumarato El cual es alternativamente seleccionado de entre un compuesto de fórmula Ik y un compuesto Ip.</p><p> A compound of formula (I) or pharmaceutically acceptable salts thereof, where the pharmaceutically acceptable salts are selected from hydrobromide, tartrate, citrate, trifluoroacetate, ascorbate, hydrochloride, tartrate, triflate, maleate, mesylate, format, acetate and fumarate Which is alternately selected from a compound of formula Ik and an compound Ip. </p>

CUP2015000028A 2009-06-12 2010-06-14 QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS CU24319B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18654409P 2009-06-12 2009-06-12
EP20090305540 EP2266972A1 (en) 2009-06-12 2009-06-12 New chemical molecules that inhibit the splicing mechanism for treating diseases resulting from splicing anomalies
PCT/IB2010/052652 WO2010143170A2 (en) 2009-06-12 2010-06-14 Compounds useful for treating premature aging and in particular progeria

Publications (2)

Publication Number Publication Date
CU20150028A7 CU20150028A7 (en) 2015-11-27
CU24319B1 true CU24319B1 (en) 2018-02-08

Family

ID=55659614

Family Applications (3)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (en) 2009-06-12 2010-06-14 QUINOLIN AND QUINOXALINA DERIVED FROM THE FORMULA (Ii), (Ij), (Ij '), (Ij' ') and (Ij' '') AND SALES DERIVED
CUP2015000025A CU24322B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED
CUP2015000028A CU24319B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA AND QUINOXALINE DERIVED FROM THE FORMULA (Ik) and (Ip) AND DERIVED SALTS

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CUP2015000027A CU24323B1 (en) 2009-06-12 2010-06-14 QUINOLIN AND QUINOXALINA DERIVED FROM THE FORMULA (Ii), (Ij), (Ij '), (Ij' ') and (Ij' '') AND SALES DERIVED
CUP2015000025A CU24322B1 (en) 2009-06-12 2010-06-14 QUINOLIN-2-AMINA DERIVATIVES OF THE FORMULA (Ig) AND SALES DERIVED

Country Status (1)

Country Link
CU (3) CU24323B1 (en)

Also Published As

Publication number Publication date
CU24323B1 (en) 2018-02-08
CU20150025A7 (en) 2015-11-27
CU20150027A7 (en) 2015-11-27
CU24322B1 (en) 2018-02-08
CU20150028A7 (en) 2015-11-27

Similar Documents

Publication Publication Date Title
CU24461B1 (en) USEFUL COMPOUNDS TO TREAT PREMATURE AGING AND IN PARTICULAR PROGERIA
NL301202I2 (en) Linzagolix, or a pharmaceutically acceptable salt thereof, such as linzagolix choline
CY1124219T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A LOCAL ANESTHETIC SUCH AS BUPIVACAIN FOR TOPICAL ADMINISTRATION INTO THE MOUTH OR PHARYNX
ATE406360T1 (en) ANTAGONISTS OF OPIOID RECEPTORS
NO20091395L (en) New thiophene derivatives
ATE446962T1 (en) THIAZOLOPYRIDINONE DERIVATIVES AS MCH RECEPTOR ANTAGONISTS
NO20072978L (en) New betuene derivatives, their preparation and their use
ATE377589T1 (en) 6-SUBSTITUTED NICOTINAMIDE DERIVATIVES AS OPIOID RECEPTOR ANTAGONISTS
ATE519764T1 (en) SPIROINDOLINONE DERIVATIVES
MX2009008541A (en) Hcv inhibiting macrocyclic phenylcarbamates.
EA201201263A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING DAGIGATRAN ETEXYLATE
WO2008005368A3 (en) Piperazines as p2x7 antagonists
EA201101398A1 (en) SUBSTITUTED PIPERIDINE AS AN ANTAGONIST CCR3
DK2235017T3 (en) Spiroindolinone derivatives as anticancer agents
ATE512961T1 (en) AMORPHIC NEBIVOLOL HYDROCHLORIDE AND ITS PRODUCTION
JP2013519683A5 (en)
MX2009004662A (en) Pyrazoline compounds as mineralocorticoid receptor antagonists.
MA32812B1 (en) Pharmaceutical composition of a powerful antagonist for oral VHC
MX2010004232A (en) Pyrimidyl indoline compound.
DK1828177T3 (en) Newly known MCH receptor antagonists
MXPA05013474A (en) Quinolyl amide derivatives as ccr-5 antagonists.
DK1814848T3 (en) 2,3,4-substituted-cyclopentanones as therapeutic agents
EA201190034A1 (en) (S) -3-Aminomethyl-7- (3-dihydroxypropoxy) -3 H -benzo [c] [1,2] oxaborol-1-
ATE308522T1 (en) OPIOID RECEPTOR ANTAGONISTS
ATE536172T1 (en) EZETIMIBE COMPOSITIONS